G Gaidano

6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma.

K Offit, N Z Parsa, R S Chaganti, 1993, Blood.

Acquired immunodeficiency syndrome-related cancer. A study model for the mechanisms contributing to the genesis of cancer.

G. Gaidano, A. Carbone, G Gaidano, 2001, European journal of cancer.

Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.

A Rzhetsky, M. Soares, M. Bonaldo, 2000, Current topics in microbiology and immunology.

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

G. Gaidano, G. Inghirami, A. Neri, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10

F Forconi, G. Gaidano, V. Gattei, 2008, Leukemia.

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

G. Abel, S. Molica, F. Mandelli, 2015, Leukemia research.

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

T. Greiner, J. Vose, M. Piris, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

B. Dörken, C. Schmitt, K. Stamatopoulos, 2017, Leukemia.

Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.

M Schena, G. Gaidano, L. Larsson, 1992, Blood.